[1] |
LI Na.
The Risk Assessment Value of Multi-parameter Echocardiography Score for Prognosis of Heart Failure Patients
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(9): 169-173.
|
[2] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(7): 187-190.
|
[3] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(2): 154-157.
|
[4] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(21): 184-187.
|
[5] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(18): 29-31.
|
[6] |
PENG Yan.
The Values of Cardiac Ultrasound Parameter Integration System in Risk Assessment of Prognosis of Patients with Heart Failure at High Altitude
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(16): 11-15.
|
[7] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(13): 59-62.
|
[8] |
GUO Xue-feng.
Dose Dependence of Valsartan Dose on Ventricular Vascular Coupling Index in Patients with Heart Failure
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(10): 51-54.
|
[9] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(7): 179-182.
|
[10] |
GUAN Jing-zhi, WANG Fei-fei, DAI Wen-jun, YUAN Shao-fei, SHI Lei.
Impact of Sacubitril/Valsartan on the Treatment Effectiveness, Serum Sirtuin-4 and Beclin-1 Levels of Chronic Heart Failure Patients
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(3): 184-188.
|
[11] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(18): 74-76.
|
[12] |
LIU Yan-yan.
Effects of Valsartan Combined with Spironolactone on Intractable Heart Failure,Coagulation Function and Cardiac Function
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(17): 7-10.
|
[13] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(15): 58-60.
|
[14] |
.
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(15): 132-135.
|
[15] |
Zhao Li-rong.
Observation on the effect of exercise training in the treatment of elderly patients with chronic heart failure and sarcopenia
[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(11): 4-7.
|